Create Alert
Watchlist

Kilitch Drugs (India)

₹338.80
+1.55 (0.46%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
338.45
Prev. Close
337.25
Volume
4,107
Total traded value
0.14 Cr
Upper Circuit
406.55
Lower Circuit
271.05

Fundamentals

Market Cap₹583Cr
ROE10.38%
P/E Ratio(TTM)22.32
EPS(TTM)14.95
P/B Ratio2.20
Dividend Yield0.00%
Industry P/E33.07
Book Value151.97
Debt to Equity0.31
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Kilitch Drugs (india) Limited.

Kilitch Drugs (India) Limited is one of the world's leading and fastest-growing pharmaceutical companies, manufacturing and supplying a broad range of formulations globally. The company embraces purpose-driven leadership to create long-term value beyond financial performance, establishing itself as a significant entity in the pharmaceutical industry. It is committed to achieving sustainable healthcare by optimizing its processes and practices through continuous innovation and sustainable operations. Its extensive research has developed a diverse portfolio targeting chronic and acute treatments, including injectables, ophthalmics, effervescent tablets, and nutraceuticals. With a formidable presence across Asia, Africa, CIS, and Latin America, the company offers a broad product portfolio to suit each country's needs. A key international asset is its Ethiopia Unit, the largest Cephalosporin plant in East Africa, producing tablets, capsules, and injectables.;
Parent OrganisationKilitch Drugs (india) Limited.
Managing DirectorMukund Mehta
Founded1992
NSE SymbolKILITCH

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
63.77%
Retail And Others
36.23%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
60.10
Ajanta Pharma
NA
(0.00%)
33.65
Gland Pharma
NA
(0.00%)
34.84
Eris Lifesciences
NA
(0.00%)
47.73
2025
13
Nov
Result
Release date
13
Aug
Quarterly Result
Release date

15
Jul
Rights Entitlement
Ex date
2:23
Ratio

2 rights eligible for every 23 existing shares held
Ratio2:23
Offer price₹357.00
Ex date15 Jul ‘25
Record date15 Jul ‘25
Announcement date9 Jul ‘25

9
Jul
Rights Entitlement
Announced
2:23
Ratio

2 rights eligible for every 23 existing shares held
Ratio2:23
Offer price₹357.00
Ex date15 Jul ‘25
Record date15 Jul ‘25
Announcement date9 Jul ‘25
19
May
Quarterly & Annual Result
Release date
11
Feb
Quarterly Result
Release date
2024
12
Nov
Quarterly Result
Release date
8
Aug
Quarterly Result
Release date
27
May
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks